Plus Therapeutics (PSTV) Stock Price, Quote, News & History | Benzinga

Plus Therapeutics Inc (PSTV) Stock Price, Quote, News & History

PSTVNASDAQ

Trade with Public

Trade with Public

$5.39

-0.11-2.00%

At close: Jun 9, 5:00 PM EST

$5.39

-0.11-2.00%

Pre-Market: 4:09 AM EST

OverviewNews Earnings Events Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

-

Close

$5.39

Volume / Avg.

192.00 / 302.77K

Day Range

- - -

52 Wk Range

2.90 - 23.43

Market Cap

$37.10M

P/E Ratio

0.25

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

16.69%

Days to Cover

6.46

Recent Plus Therapeutics Inc News

Why Is Plus Therapeutics Stock Gaining Friday?

Plus Therapeutics stock jumps after FDA grants Orphan Drug status to Reyobiq for pediatric brain cancer, boosting long-term outlook.

Vandana Singh

Penny Cancer Stock Plus Therapeutics Raises $15 Million At Discount, Stock Plunges

Plus Therapeutics stock falls in premarket trading after pricing a $15 million public offering, with proceeds set for working capital as the company develops cancer treatments.

Vandana Singh

Plus Therapeutics Announces National Coverage Agreement with UnitedHealthcare For CNS Cancer Diagnostic Kit

CNSide Diagnostics, a wholly-owned subsidiary of Plus Therapeutics, Inc. (NASDAQ: PSTV), has signed a national agreement with UnitedHealthcare insurance company, a unit of UnitedHealth Group Inc. (NYSE:

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-20.84M

Investing Cash Flow (TTM)

-12.95M

Financing Cash Flow (TTM)

26.94M

Free Cash Flow (TTM)

-21.72M

Capital Expenditure (TTM)

-882.00K

Net Change in Cash (TTM)

-6.85M

Analyst Trends and Forecast

3

Jan

1

Mar

1

Apr

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$22.72M

PE Ratio (TTM)

0.25

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.10

Earnings Yield % (TTM)

400.00%

Earnings Yield % (FWD)

-66.23%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.74

Company Debt

Total Debt

$667.00K

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$3.02M

Debt to Equity

0.06

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-$1.10M

Key Statistics

Open

-

Close

$5.39

Volume / Avg.

192.00 / 302.77K

Day Range

- - -

52 Wk Range

2.90 - 23.43

Market Cap

$37.10M

P/E Ratio

0.25

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

16.69%

Days to Cover

6.46

About

Sector

Health Care

Industry

Biotechnology

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential pro...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Plus Therapeutics (PSTV) stock?

A

You can purchase shares of Plus Therapeutics (NASDAQ:PSTV) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Plus Therapeutics (PSTV) competitors?

A

There are no as such competitors for Plus Therapeutics.

Q

What is the forecast, or price target, for Plus Therapeutics (PSTV) stock?

A

Plus Therapeutics has a consensus price target of $20.33.

Q

What is the current price for Plus Therapeutics (PSTV)?

A

The stock price for Plus Therapeutics (NASDAQ: PSTV) is $5.39 last updated June 11, 2026 at 5:10 AM EDT.

Q

Does Plus Therapeutics (PSTV) pay a dividend?

A

There are no upcoming dividends for Plus Therapeutics.

Q

When is Plus Therapeutics (NASDAQ:PSTV) reporting earnings?

A

Plus Therapeutics does not have any upcoming earnings scheduled.

Q

Is Plus Therapeutics (PSTV) going to split?

A

There is no upcoming split for Plus Therapeutics.

Q

What sector and industry does Plus Therapeutics (PSTV) operate in?

A

Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.